Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Baxter
AstraZeneca
Medtronic
Colorcon

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

BACTROBAN Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Bactroban, and when can generic versions of Bactroban launch?

Bactroban is a drug marketed by Glaxosmithkline and is included in three NDAs.

The generic ingredient in BACTROBAN is mupirocin. There are sixteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the mupirocin profile page.

US ANDA Litigation and Generic Entry Outlook for Bactroban

  Start Trial

A generic version of BACTROBAN was approved as mupirocin by PERRIGO ISRAEL on January 17th, 2020.

Drug patent expirations by year for BACTROBAN
Drug Prices for BACTROBAN

See drug prices for BACTROBAN

Drug Sales Revenue Trends for BACTROBAN

See drug sales revenues for BACTROBAN

Recent Clinical Trials for BACTROBAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Jewish HealthPhase 2
University of Texas Southwestern Medical CenterPhase 2
Cook Children's Medical CenterPhase 2

See all BACTROBAN clinical trials

Pharmacology for BACTROBAN
Synonyms for BACTROBAN
(E)-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-Epoxy-5-hydroxy-4-methylhexyl)tetrahydro-3,4-dihydroxy-beta-methyl-2H-pyran-2-crotonic acid, ester with 9-hydroxynonanoic acid
115074-43-6
12650-69-0
1jzs
5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-[2E,8[2S,3S(1S,2S)]]-L-talonon-2-enonic acid 8-carboxyoctyl ester
6-Chloro-2,4-dimethoxy pyrimidine
62916-63-6
8-Carboxyoctyl (E)-4-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylcrotonat
80558-54-9
9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoic acid
9-((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)-tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyloxy)nonanoic acid
9-((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyloxy)nonanoic acid
9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)-oxiranylmethyl]-tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)-nonanoic acid
9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid calcium salt
9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt
9-({(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl}oxy)nonanoic acid
9-(4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)-tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyloxy)nonanoic acid
9-(4-{3,4-Dihydroxy-5-[3-(2-hydroxy-1-methyl-propyl)-oxiranylmethyl]-tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)-nonanoic acid (Mupirocin)
9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3- [(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl] oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid
9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methyl-propyl]oxiran-2-yl]methyl]tetrahydropyran-2-yl]-3-methyl-but-2-enoyl]oxynonanoic acid
9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid
9-{[(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-{[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl}oxan-2-yl]-3-methylbut-2-enoyl]oxy}nonanoic acid
AB0010371
AB01563109_01
AC1L9JV4
AK544341
AKOS015994756
AOB6353
AS-11580
Bactoderm
Bactroban (TN)
Bactroban Nasal
Bactroban Ointment
BC656995
BDBM50290686
BIDD:GT0320
BRD-K15262564-001-06-9
BRL 4910A
BRL-4910A
C11758
C26H44O9
CAS-12650-69-0
CCG-213522
Centany
Centany (TN)
CHEBI:7025
CHEBI:94519
CHEMBL719
cid_446596
CPD000471888
D01076
D0GX863OA5
DB00410
DSSTox_CID_26438
DSSTox_GSID_46438
DSSTox_RID_81614
DTXSID0046438
HMS2234E20
HMS3259L05
HMS3712K03
HY-B0958
KS-5137
LS-177887
M-8680
M2955
MFCD01711620
MFCD11977847
MINDHVHHQZYEEK-HBBNESRFSA-N
MLS001074711
MolPort-003-666-882
MRC
Mupirocin
Mupirocin (USP/INN)
Mupirocin [USAN:USP:INN:BAN]
mupirocin calcium salt
mupirocin lithium salt
Mupirocin Neo-Sensitabs
Mupirocin, >=92% (HPLC), powder
Mupirocin, 14C-Labeled
Mupirocin, Antibiotic for Culture Media Use Only
Mupirocin, Pseudomonic Acid A
Mupirocin, United States Pharmacopeia (USP) Reference Standard
Mupirocin,(S)
Mupirocina
Mupirocina [Spanish]
Mupirocine
Mupirocine [French]
Mupirocinum
Mupirocinum [Latin]
NC00620
NCGC00164554-03
NCGC00164554-05
Nonanoic acid, 9-((3-methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1-methylpropyl)oxiranyl)methyl)-2H-pyran-2-yl)-2-butenyl)oxy)-, (2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))-
NSC-759182
NSC759182
Pharmakon1600-01505706
Plasimine
Pseudomonic acid
Pseudomonic acid A
Pseudomonic acid A lithium salt
S4297
SAM002589979
SBI-0206892.P001
SC-16672
SCHEMBL1027618
SCHEMBL3291
SMR000471888
SR-05000001947
SR-05000001947-1
SR-05000001947-2
Tox21_112183
trans-Pseudomonic acid
Turixin
UNII-D0GX863OA5
ZINC4102194

US Patents and Regulatory Information for BACTROBAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline BACTROBAN mupirocin calcium CREAM;TOPICAL 050746-001 Dec 11, 1997 DISCN Yes No   Start Trial   Start Trial   Start Trial
Glaxosmithkline BACTROBAN mupirocin calcium OINTMENT;NASAL 050703-001 Sep 18, 1995 DISCN Yes No   Start Trial   Start Trial   Start Trial
Glaxosmithkline BACTROBAN mupirocin OINTMENT;TOPICAL 050591-001 Dec 31, 1987 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for BACTROBAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline BACTROBAN mupirocin calcium CREAM;TOPICAL 050746-001 Dec 11, 1997   Start Trial   Start Trial
Glaxosmithkline BACTROBAN mupirocin calcium CREAM;TOPICAL 050746-001 Dec 11, 1997   Start Trial   Start Trial
Glaxosmithkline BACTROBAN mupirocin calcium OINTMENT;NASAL 050703-001 Sep 18, 1995   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Mallinckrodt
Harvard Business School
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.